The artificial membrane insert system as predictive tool for formulation performance evaluation.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  International journal of pharmaceutics

• Publication date

  2018-02-15

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1016/j.ijpharm.2017.12.025PMID 29241703
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Assessment of Passive Intestinal Permeability Using an Artificial Membrane Insert System.

  2018cited by this paper
• Evaluation of a dynamic dissolution/permeation model: Mutual influence of dissolution and barrier-flux under non-steady state conditions.

  2017cited by this paper
• Dissolution and dissolution/permeation experiments for predicting systemic exposure following oral administration of the BCS class II drug clarithromycin

  2017cited by this paper
• Gastrointestinal behavior of itraconazole in humans - Part 2: The effect of intraluminal dilution on the performance of a cyclodextrin-based solution.

  2017cited by this paper
• 50years of oral lipid-based formulations: Provenance, progress and future perspectives.

  2016cited by this paper
• Effect of cyclodextrin concentration on the oral bioavailability of danazol and cinnarizine in rats.

  2016cited by this paper
• Pharmaceutics, Drug Delivery and Pharmaceutical Technology Characterization of Human Duodenal Fluids in Fasted and Fed State Conditions

  2016cited by this paper
• The solubility-permeability interplay and oral drug formulation design: Two heads are better than one.

  2016cited by this paper
• Characterization of Human Duodenal Fluids in Fasted and Fed State Conditions.

  2016cited by this paper
• Supersaturation and Precipitation of Posaconazole Upon Entry in the Upper Small Intestine in Humans.

  2015cited by this paper
• Gastrointestinal behavior of nano- and microsized fenofibrate: In vivo evaluation in man and in vitro simulation by assessment of the permeation potential.

  2015cited by this paper
• Human and simulated intestinal fluids as solvent systems to explore food effects on intestinal solubility and permeability.

  2014cited by this paper
• Characterization and evaluation of a modified PVPA barrier in comparison to Caco-2 cell monolayers for combined dissolution and permeation testing.

  2014cited by this paper
• Gastrointestinal transfer: in vivo evaluation and implementation in in vitro and in silico predictive tools.

  2014cited by this paper
• Strategies to Address Low Drug Solubility in Discovery and Development

  2013cited by this paper
• Exploring food effects on indinavir absorption with human intestinal fluids in the mouse intestine.

  2013cited by this paper
• Evaluation of gastrointestinal drug supersaturation and precipitation: strategies and issues.

  2013cited by this paper
• The use of amorphous solid dispersions: A formulation strategy to overcome poor solubility and dissolution rate.

  2012cited by this paper
• Drug precipitation-permeation interplay: supersaturation in an absorptive environment.

  2012cited by this paper
• Accounting for the solubility-permeability interplay in oral formulation development for poor water solubility drugs: the effect of PEG-400 on carbamazepine absorption.

  2012cited by this paper
• The solubility-permeability interplay when using cosolvents for solubilization: revising the way we use solubility-enabling formulations.

  2012cited by this paper
• Application of Dissolution/Permeation System for Evaluation of Formulation Effect on Oral Absorption of Poorly Water-Soluble Drugs in Drug Development

  2011cited by this paper
• Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications.

  2011cited by this paper
• Intestinal drug solubility estimation based on simulated intestinal fluids: comparison with solubility in human intestinal fluids.

  2011cited by this paper
• Drug supersaturation in simulated and human intestinal fluids representing different nutritional states.

  2010cited by this paper
• Solubility increases associated with crystalline drug nanoparticles: methodologies and significance.

  2010cited by this paper
• The solubility-permeability interplay in using cyclodextrins as pharmaceutical solubilizers: mechanistic modeling and application to progesterone.

  2010cited by this paper
• Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability?

  2009cited by this paper
• Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories.

  2008cited by this paper
• Nucleation and crystal growth in supersaturated solutions of a model drug.

  2008cited by this paper
• Comparative interaction of 2-hydroxypropyl-beta-cyclodextrin and sulfobutylether-beta-cyclodextrin with itraconazole: phase-solubility behavior and stabilization of supersaturated drug solutions.

  2008cited by this paper
• Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs

  2007cited by this paper
• Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug.

  2007cited by this paper
• Cyclodextrins as pharmaceutical solubilizers.

  2007cited by this paper
• Clinical study of solid dispersions of itraconazole prepared by hot-stage extrusion.

  2005cited by this paper
• A Dynamic Artificial Gastrointestinal System for Studying the Behavior of Orally Administered Drug Dosage Forms Under Various Physiological Conditions

  2004cited by this paper
• In Vitro System to Evaluate Oral Absorption of Poorly Water-Soluble Drugs: Simultaneous Analysis on Dissolution and Permeation of Drugs

  2003cited by this paper
• Solubilization of Drugs by Physiological Mixtures of Bile Salts

  2002cited by this paper
• Graphical model for estimating oral bioavailability of drugs in humans and other species from their Caco-2 permeability and in vitro liver enzyme metabolic stability rates.

  2002cited by this paper
• Evaluation of Various Dissolution Media for Predicting In Vivo Performance of Class I and II Drugs

  1998cited by this paper
• A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability

  1995cited by this paper
• Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability.

  1989cited by this paper

• Engineered nanofibrous membrane as an in-vitro corneal model for drug permeation studies.

  2025cites this paper
• Establishing clinically relevant dissolution specifications for prodrug bioequivalence risk assessment: Integration of a dissolution/permeation system with physiologically based biopharmaceutics modeling in abiraterone acetate.

  2025cites this paper
• Comparison of lipophilic and size-exclusion membranes: creating sink conditions with cyclodextrin

  2025cites this paper
• Comparison of lipophilic and size-exclusion membranes: the effect of stirring and cyclodextrin in the donor compartment

  2025cites this paper
• A Review on Microengineering of Epithelial Barriers for Biomedical and Pharmaceutical Research.

  2024cites this paper
• Supersaturation and Precipitation Applicated in Drug Delivery Systems: Development Strategies and Evaluation Approaches

  2023cites this paper
• The Dynamic Intestinal Absorption Model (Diamod®), an in vitro tool to study the interconnected kinetics of gastrointestinal solubility, supersaturation, precipitation, and intestinal permeation processes of oral drugs

  2023cites this paper
• In vitro and ex vivo experimental models for evaluation of intranasal systemic drug delivery as well as direct nose‐to‐brain drug delivery

  2023cites this paper
• In-vitro dynamic dissolution/bioconversion/permeation of fosamprenavir using a novel tool with an artificial biomimetic permeation barrier and microdialysis-sampling.

  2022cites this paper
• Approaches of formulation bridging in support of orally administered drug product development.

  2022cites this paper
• Interaction of Polymers with Enzalutamide Nanodroplets-Impact on Droplet Properties and Induction Times.

  2021cites this paper
• Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP network.

  2021cites this paper
• Prediction of in vivo supersaturation and precipitation of poorly water-soluble drugs: achievements and aspirations.

  2021cites this paper
• Role of Permeability on the Biopredictive Dissolution of Amorphous Solid Dispersions

  2021cites this paper
• Combined Methodologies for Determining In Vitro Bioavailability of Drugs and Prediction of In Vivo Bioequivalence From Pharmaceutical Oral Formulations

  2021cites this paper
• Human artificial membranes in (bio)analytical science: Potential for in vitro prediction of intestinal absorption-A review

  2021cites this paper
• Best practices in current models mimicking drug permeability in the gastrointestinal tract - an UNGAP review.

  2021cites this paper
• Amorphous solid dispersions of enzalutamide and novel polysaccharide derivatives: investigation of relationships between polymer structure and performance

  2020cites this paper
• Leveraging bile solubilization of poorly water-soluble drugs by rational polymer selection.

  2020cites this paper
• In Vitro Biopredictive Methods: A Workshop Summary Report.

  2020cites this paper
• Biopredictive in vitro testing methods to assess intestinal drug absorption from supersaturating dosage forms

  2020cites this paper
• Six years of progress in the oral biopharmaceutics area - a summary from the IMI OrBiTo project.

  2020cites this paper
• An in vitro dissolution-digestion-permeation assay for the study of advanced drug delivery systems.

  2020cites this paper
• Types and evaluation of in vitro penetration models for buccal mucosal delivery

  2020cites this paper
• Artificial membranes in combination with selected natural oils for in vitro drug passive diffusion screening in Ussing type chamber apparatus applied to gastro-retentive systems

  2019cites this paper
• Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems.

  2019cites this paper
• In vitro models for the prediction of in vivo performance of oral dosage forms: Recent progress from partnership through the IMI OrBiTo collaboration

  2019cites this paper
• Artificial membranes soaked with natural oils for in vitro drug premeability evaluations

  2019influential citation
• Gastric and Duodenal Diclofenac Concentrations in Healthy Volunteers after Intake of the FDA Standard Meal: In Vivo Observations and in Vitro Explorations.

  2019cites this paper
• Evaluating side‐by‐side diffusion models for studying drug supersaturation in an absorptive environment: a case example of fenofibrate and felodipine

  2019influential citation
• Syddansk Universitet Drug permeability profiling using cell-free permeation tools Overview and applications

  2018cites this paper
• Measuring the Impact of Gastrointestinal Variables on the Systemic Outcome of Two Suspensions of Posaconazole by a PBPK Model

  2018cites this paper
• Drug permeability profiling using cell-free permeation tools: Overview and applications.

  2018influential citation
• The effect of 2‐hydroxypropyl‐&bgr;‐cyclodextrin on the intestinal permeation through mucus

  2018cites this paper
• In vitro methods to assess drug precipitation in the fasted small intestine – a PEARRL review

  2018influential citation